Journal
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Volume 186, Issue -, Pages -Publisher
ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
DOI: 10.1016/j.ejmech.2019.111879
Keywords
Adenosine receptors; A(1) adenosine receptor; A(3) adenosine receptor antagonist; Allosteric modulator; Alzheimer's disease; Inverse agonist; Multi-target drugs; Selectivity; Species differences; Structure-activity relationships; Synthesis; Thiazole
Categories
Funding
- National Natural Science Foundation of China [81872729, 81230077]
- Program for Innovative Research Team of the Ministry of Education
- Program for Liaoning Innovative Research Team in University
Ask authors/readers for more resources
Adenosine acts as a powerful signaling molecule via four distinct G protein-coupled receptors, designated A(1), A(2A), A(2B) and A(3) adenosine receptors (ARs). A(2A) and A(2B) ARs are G(s)-coupled, while A(1) and A(3) ARs inhibit cAMP production via G, proteins. Antagonists for A(1) and A(3) ARs may be useful for the treatment of (neuro)inflammatory diseases including acute kidney injury and kidney failure, pulmonary diseases, and Alzheimer's disease. In the present study, we optimized the versatile 2-amino-4-phenylthiazole scaffold by introducing substituents at N2 and C5 to obtain A t and A3 AR antagonists including dual-target compounds. Selective A(1) antagonists with (sub)nanomolar potency were produced, e.g. 11 and 13. These compounds showed species differences being significantly more potent at the rat as compared to the human A(1) AR, and were characterized as inverse agonists. Several potent and selective A(3) AR antagonists, e.g. 7, 8, 17 and 22 (K-i values of 5-9 nM at the human A(3) AR) were prepared, which were much less potent at the rat orthologue. Moreover, dual A(1)/A(3) antagonists (10, 18) were developed showing K-i values between 8 and 42 nM. Docking and molecule dynamic simulation studies using the crystal structure of the A(1) AR and a homology model of the A(3) AR were performed to rationalize the observed structure-activity relationships. (C) 2019 Elsevier Masson SAS. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available